New Progress of Epigenetic Biomarkers in Urological Cancer

Table 2

Overview of kidney cancer biomarkers.

Biomarker	Sample	Type	Diagnosis, treatment, or prognosis
Kidney cancer
Wnt family genes	Tissue (serum)	DNA methylation	Diagnosis, prognosis
VHL, RASSF1A	Tissue	DNA methylation	Diagnosis
SMPD3, FBXW10	Tissue	Hypermethylation	Diagnosis
DAB2IP	Tissue	Methylation	Prognosis
H3K4me2, H3K18Ac	Tissue	Histone modification	Prognosis
hMOF	Tissue	Histone modification	Diagnosis
HDAC	Tissue	Histone modification	Treatment
miRNA-126	Tissue	Downregulated	Treatment
miR-146a-5p; miR-128a-3p; miR-17-5p	Tissue	Downregulated	Prognosis